Louisville, Colorado 80027


Purpose:

This study evaluates the performance of eight (8) cleared capnography carbon dioxide (CO2) sampling filterlines during patient simulated scripted activities when connected to a Medtronic (MDT) monitor.


Study summary:

The eight (8) Capnography CO2 Sampling Filterlines (CCSF) have different designs for obtaining a gas sample for measurement and delivering supplemental oxygen (O2). In this study awake, healthy volunteers will evaluate the 8 CCSF (Capnography CO2 Sampling Filterline) to determine their variability in detecting exhaled CO2 during scripted activities when altering the delivery of supplemental O2.


Criteria:

Inclusion Criteria: 1. Non-hospitalized adults ≥ 18 years old. 2. Willing and able to give informed consent. Exclusion Criteria: 1. Lack of an informed consent. 2. Subjects not able to accommodate the proper application of the cannula. 3. Subject not willing or able to comply fully with the study procedures. 4. Subjects with sensitivity to nasal cannula in both nares. 5. Subject with skin allergies to medical adhesives. 6. Subjects with runny nose the day of the study participation. 7. Subject, who in the opinion of the Principal Investigator, should not be enrolled.


NCT ID:

NCT03554629


Primary Contact:

Principal Investigator
Thomas A Miner, MD
Clinimark, LLC

Paul Batchelder, RRT
Phone: 303-717-4820
Email: PBatchelder@Climimark.com


Backup Contact:

N/A


Location Contact:

Louisville, Colorado 80027
United States

Paul Batchelder, RRT
Phone: 303-717-4820
Email: PBatchelder@clinimark.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.